Unleashing the power of immune cell interactions

Our immune system is the most powerful tool to defeat cancer
Tumors adapt to drugs, so we need an adaptable system to outsmart them
But we still don’t know how to manipulate immune responses effectively
Rare interactions between immune cells can trigger an unexpected domino effect

We leverage AI-powered microscopy and spatial analytics from human tumors to design precision immunotherapies targeting immune-immune cell interactions.

Voyant Bio Selected for Merck Digital Sciences Studio

Voyant Bio is proud to announce its acceptance into the latest cohort of the Merck Digital Sciences Studio (MDS Studio), a digital accelerator designed to enable the next generation of technologies for drug discovery and development, including artificial intelligence and machine learning. MDS Studio was founded to offer support for early-stage biomedical startups providing strategic guidance, direct investment, and connection opportunities within Merck.

About Merck Digital Sciences Studio
The Merck Digital Sciences Studio (MDS Studio or MDSS), a collaboration between Merck, Merck Global Health Innovation Fund, Northpond Ventures, McKesson Ventures, Microsoft for Startups, and the New Jersey Innovation Institute, a New Jersey Institute of Technology (NJIT) subsidiary. The 10-month startup accelerator program, with direct investments from Merck Global Health Innovation Fund, Northpond Ventures, and McKesson Ventures, empowers members and enables the generation of innovative digital technologies for drug discovery and development through hands-on mentorship, connection opportunities with industry-leading partners, and training in an active entrepreneurial setting. Through the accelerator program, these startups will have access to workshops, coaching, office space, and Microsoft for Startups Founders Hub resources, including up to $150,000 Azure Cloud computing credits.

Leadership

Assaf Magen, Ph.D., CEO & CSO

Voyant is led by an established team including Assaf Magen, PhD, CEO & CSO, an expert in immuno-oncology and computational biology, inventor of the technology, and lead author of a seminal publication. Together with a world-class biopharma advisory team, we are uniquely positioned to make breakthroughs in overcoming resistance to immunotherapy.

Founding computational biologist role

About Us: Response and resistance to cancer immunotherapy are driven by complex immune-immune cell interactions within tumors. Voyant Bio leverages multi-modal omics and microscopy on human tumors to design precision immunotherapies targeting immune-immune cell interactions. Our approach unlocks opportunities for transformative therapeutic breakthroughs, aiming to significantly improve cancer patient outcomes. We are a backed by Merck Digital Sciences Studio, a collaborative effort by Merck and the New Jersey Innovation Institute.Who We Are: Our team is led by Assaf Magen, PhD, CEO & CSO, an expert in immuno-oncology and computational biology, inventor of the technology, and lead author of a seminal publication. He trained at the National Cancer Institute (NCI, NIH) and served as an assistant professor at Mount Sinai. Together with a world-class biopharma advisory team, we are uniquely positioned to make breakthroughs in overcoming resistance to immunotherapy.The Role: We are looking for a founding Machine Learning/Computational Biology scientist to lead our technical efforts, focusing on multi-modal omics, spatial data analysis, and method development. You’ll be instrumental in shaping the bioinformatics roadmap and building scalable platforms and generative models for diverse biological datasets. This role requires hands-on experience in Python for single-cell genomics and microscopy data analysis, as well as expertise in large-scale data management in cloud environments. A strong foundation in AI-driven approaches to biological data interpretation and modeling is essential. Ideally, you have recruited, managed, and led a computational biology or machine learning team. Exposure to immunology or immuno-oncology is a plus. This is a founding scientist position with incredible room for growth in responsibilities and benefits as we grow.Email us at [email protected].

Voyant Bio
Manipulating immunity to outsmart cancer

© Voyant Bio. All rights reserved.